The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?
Cardiovascular Drugs and Therapy · 2023-10 · 37 (5) · 847-848
DOI: 10.1007/s10557-022-07375-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 24.08.2022. Verfasst von Qian-Feng Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Liaocheng People's Hospital Affiliated to Shandong First Medical University, Liaocheng, People's Republic of China. Hauptthemen laut MEDLINE: Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Liaocheng People's Hospital Affiliated to Shandong First Medical University, Liaocheng, People's Republic of China.
- Department of Cardiology, Liaocheng People's Hospital Affiliated to Shandong First Medical University, Liaocheng, People's Republic of China. modegang1314@163.com.
ORCID-Profile: De-Gang Mo
Zitieren
APA
Han, Q. F., Liu, J. H., & Mo, D. G. (2023). The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?. Cardiovascular Drugs and Therapy, 37(5), 847-848. https://doi.org/10.1007/s10557-022-07375-3
Vancouver
Han QF, Liu JH, Mo DG. The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?. Cardiovascular Drugs and Therapy. 2023;37(5):847-848. doi:10.1007/s10557-022-07375-3
BibTeX
@article{Han2023,
author = {Han, Qian-Feng and Liu, Jia-Hui and Mo, De-Gang},
title = {The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?},
journal = {Cardiovascular Drugs and Therapy},
year = {2023},
volume = {37},
number = {5},
pages = {847--848},
doi = {10.1007/s10557-022-07375-3}
}
EUVIMED